Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Notes Payables: 2015-2025

Historic Notes Payables for HUTCHMED (China) (HCM) over the last 3 years, with Jun 2025 value amounting to $67.8 million.

  • HUTCHMED (China)'s Notes Payables rose 1718.34% to $67.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $67.8 million, marking a year-over-year increase of 1718.34%. This contributed to the annual value of $23.4 million for FY2024, which is 24.98% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Notes Payables stood at $67.8 million, which was up 190.27% from $23.4 million recorded in Q4 2024.
  • Over the past 5 years, HUTCHMED (China)'s Notes Payables peaked at $67.8 million during Q2 2025, and registered a low of -$26.9 million during Q2 2022.
  • Over the past 3 years, HUTCHMED (China)'s median Notes Payables value was $31.2 million (recorded in 2023), while the average stood at $31.7 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Notes Payables tumbled by 200.15% in 2022, and later skyrocketed by 1,718.34% in 2025.
  • Quarterly analysis of 5 years shows HUTCHMED (China)'s Notes Payables stood at $26.9 million in 2021, then slumped by 200.07% to -$26.9 million in 2022, then spiked by 215.72% to $31.2 million in 2023, then decreased by 24.98% to $23.4 million in 2024, then surged by 1,718.34% to $67.8 million in 2025.
  • Its Notes Payables was $67.8 million in Q2 2025, compared to $23.4 million in Q4 2024 and -$4.2 million in Q2 2024.